New York medical school taps EVMS physician/scientist as new dean
Jerry Nadler, MD, a veteran medical educator, widely respected administrator and a former scientist of the year in Virginia, will soon take on a new role: leadership of a medical school.
In March 2019, Dr. Nadler will leave EVMS to become Dean of the New York Medical College School of Medicine in Valhalla, New York. NYMC is part of the Touro College and University System — the largest private university in the U.S. under Jewish auspices.
EVMS recruited Dr. Nadler from the University of Virginia in 2008. He has served as the Harry H. Mansbach Chair in Internal Medicine, Vice Dean for Research and Professor and Chair of Internal Medicine. EVMS will launch a national search for a new Chair of Internal Medicine.
Richard Homan, MD, President and Provost of EVMS and Dean of the School of Medicine, says Dr. Nadler leaves an indelible mark on the institution.
“During his 10 years at EVMS, Dr. Nadler has provided exceptional leadership for the Internal Medicine department, recruited outstanding faculty and lent his extensive knowledge and experience to the teaching of our students and residents,” Dr. Homan said in a Sept. 21 announcement to campus. “As a physician researcher, Dr. Nadler has enhanced our research reputation by attracting outstanding researchers to EVMS, earning significant grants and publishing high-caliber scholarly articles.
“Since his appointment as Vice Dean of Research in September 2013, Dr. Nadler has provided executive leadership and strategic oversight of our research enterprise while strengthening our infrastructure, enhancing our translational research capabilities and promoting collaboration with our strategic partners,” he said.
Dr. Nadler has helped propel science’s understanding of diabetes through his study of the role of lipid and immune inflammatory pathways leading to diabetes and complications of the disease. Dr. Nadler also is working to identify new biomarkers to signal the development of Type 1 diabetes and ways to prevent disease development.
Dr. Nadler has research funding from the National Institutes of Health and JDRF. He has been a part of the Human Islet Research Network at the National Institute of Diabetes and Digestive and Kidney Diseases, and he has more than 200 peer-reviewed publications and several patents related to his therapeutic discoveries. He has been an invited speaker at the American Diabetes Association, Australian Diabetes Association, World Diabetes Congress and European Association of Diabetes.
For the past three years, the Diabetes and Endocrinology program at Sentara Norfolk General Hospital — staffed by specialists from EVMS Endocrinology and Metabolism and the EVMS Strelitz Diabetes Center — has earned a spot in U.S. News & World Report’s Top 50. In 2018, the ranking climbed to 31 from 43 in the previous year thanks to Dr. Nadler’s leadership.
In 2016, on the strength of his work in diabetes, Dr. Nadler was chosen Outstanding Scientist of the Year in Virginia.
Dr. Nadler is Co-Chair of the Board of Directors of the Virginia Biosciences Health Research Corporation and participates with other senior research deans on a state task force to increase bioscience in Virginia. In 2015 he was awarded Mastership in the American College of Physicians in recognition of his contributions to mentoring and research.
He continues to see patients and has been listed in top doctor rankings continuously for the last 15 years.